ASTANA. KAZINFORM “Coronavirus cases will be recorded every year,” said Kazakhstan’s Deputy Minister of Health and Chief Health Officer Aizhan Yesmagambetova.
She said COVID will stay with us forever. ” It has taken its position on the environment. Coronavirus infection will be recorded year after year, as well as influenza and acute respiratory viral illnesses. The only thing that is unknown is its seasonal occurrence. diseases are recorded between October and April, while COVID is detected throughout the year. For example, Kazakhstan reported an increase in coronavirus cases in the summer, then at the end of the year and at the beginning of the year, in December and January,” he said at today’s press conference.
Earlier, he said coronavirus cases increased 2. 3-fold in December in Kazakhstan to November.
“In November this year, Kazakhstan showed the flow of the Omisron coronavirus strain, adding 0. 5% of the Cerberus variant and 99. 5% of other types of Omicron. The Cerberus strain has been detected in 65 countries around the world and differs from the past bureaucracy of omicron. Its symptoms resemble the symptoms of an acute respiratory viral illness”, ed.
He added that Kazakhstan daily reports up to three hundred new positive cases of coronavirus and 20 negative cases of coronavirus.
“Since August 12, Kazakhstan remains in the COVID green zone, the R-value is above 1 in thirteen regions, but for Zhetysu, Atyrau, Zhambyl, Kyzylorda, northern Kazakhstan, which means that COVID cases continue to grow,” he continued.
The Deputy Minister recalled that vaccination is the only way to protect oneself from the coronavirus. 5. 7 million or 70. 5% of the eligible population were revaccinated, 1. 2 million or 54. 8% of the eligible population gained a booster. About 120 more people are vaccinated against COVID daily on average, 2,600 are revaccinated and 4,300 get boosters.
“The QazVac, Sinofarm and Pfizer vaccines are now available in Kazakhstan. There are 98,000 doses of QazVac, 306,000 doses of Sinofarm and 71,000 doses of Pfizer in Kazakhstan,” Yesmagambostova said.
He said hospital admissions stand at thirteen percent (309 beds), four percent or 17 extensive care beds are occupied to date.